TR200401906T4 - Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır. - Google Patents

Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır.

Info

Publication number
TR200401906T4
TR200401906T4 TR2004/01906T TR200401906T TR200401906T4 TR 200401906 T4 TR200401906 T4 TR 200401906T4 TR 2004/01906 T TR2004/01906 T TR 2004/01906T TR 200401906 T TR200401906 T TR 200401906T TR 200401906 T4 TR200401906 T4 TR 200401906T4
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
proton pump
pump inhibitor
composition
optional
Prior art date
Application number
TR2004/01906T
Other languages
Unknown language ( )
English (en)
Inventor
Holmberg Christina
Siekmann Britta
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200401906T4 publication Critical patent/TR200401906T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Bu icat agizdan alim için uygun bir emülsiyon ön konsantresi biçiminde olan, (i) bir ya da daha fazla NO açiga çikaran NSAID(ler)'den; (ii) bir yada daha fazla yüzey aktif maddeden;(iii) seçime bagli olarak ek bir sivi ya da yari kati yagdan olusan bir farmasötik bilesim açiklamakta ve isteminde bulunmaktadir ki, sözü edilen bilesim mide-bagirsak sivilariyla temas ettiginde bir yerinde su-içinde-sivi yag emülsiyonu olusturur. Bu bilesim istege bagli olarak bir ya da daha fazla kisa zincirli alkol de içerebilir. Ayrica, icadin kapsami içinde, bir proton pompasi inhibitörü ile yapilan bir kombinasyon da vardir. Bu farmasötik bilesim agri ve inflamasyon tedavisinde yararlidir. Ayrica, icadin kapsami içinde, icatta belirtilen farmasötik bir bilesimin birim dozaj biçiminin bir proton pompasi inhibitörüyle kombinasyon halinde bulundugu ve sözü edilen proton pompasi inhibitörünün enterik kaplamali oldugu bir kit de bulunmaktadir.
TR2004/01906T 2000-03-08 2001-03-06 Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır. TR200401906T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000773A SE0000773D0 (sv) 2000-03-08 2000-03-08 New formulation

Publications (1)

Publication Number Publication Date
TR200401906T4 true TR200401906T4 (tr) 2004-09-21

Family

ID=20278739

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01906T TR200401906T4 (tr) 2000-03-08 2001-03-06 Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır.

Country Status (30)

Country Link
US (1) US20030161846A1 (tr)
EP (1) EP1267832B1 (tr)
JP (1) JP4663197B2 (tr)
KR (1) KR100771317B1 (tr)
CN (2) CN101862453A (tr)
AT (1) ATE268162T1 (tr)
AU (2) AU3787601A (tr)
BR (1) BR0109014A (tr)
CA (1) CA2401498C (tr)
CZ (1) CZ20023005A3 (tr)
DE (1) DE60103627T2 (tr)
DK (1) DK1267832T3 (tr)
EE (1) EE200200500A (tr)
ES (1) ES2220728T3 (tr)
HU (1) HUP0300882A3 (tr)
IL (1) IL151427A0 (tr)
IS (1) IS6539A (tr)
MX (1) MXPA02008657A (tr)
MY (1) MY127237A (tr)
NO (1) NO20024272L (tr)
NZ (1) NZ521009A (tr)
PL (1) PL202683B1 (tr)
PT (1) PT1267832E (tr)
RU (1) RU2270675C9 (tr)
SE (1) SE0000773D0 (tr)
SK (1) SK285982B6 (tr)
TR (1) TR200401906T4 (tr)
UA (1) UA82979C2 (tr)
WO (1) WO2001066088A1 (tr)
ZA (1) ZA200206740B (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
SE0200895D0 (sv) * 2002-03-22 2002-03-22 Astrazeneca Ab New pharmaceutical composition
ITMI20021392A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
AU2003261281A1 (en) 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
WO2004012659A2 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
SE0301880D0 (sv) * 2003-06-25 2003-06-25 Astrazeneca Uk Ltd New drug delivery composition
KR20050034299A (ko) * 2003-10-09 2005-04-14 한국유나이티드제약 주식회사 아세클로페낙 자가유화에멀젼 및 이를 이용한 연질캅셀제조성물 및 그의 제조방법
ATE485033T1 (de) * 2005-07-26 2010-11-15 Nicox Sa Pharmazeutische formulierung von nitrooxy- derivaten von nsar
EP1965774A2 (en) * 2005-12-30 2008-09-10 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
EP2367542B1 (en) * 2008-12-03 2014-01-01 Astellas Deutschland GmbH Oral dosage forms of bendamustine
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
JP5607736B2 (ja) * 2009-07-07 2014-10-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃ型肝炎ウイルスプロテアーゼ阻害剤のための医薬組成物
EP2488022B1 (en) 2009-10-16 2018-01-10 Mochida Pharmaceutical Co., Ltd. Compositions
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
CN102614115B (zh) * 2012-04-26 2013-05-15 河南中医学院 一种双氯芬酸钠自乳化软膏
ES2957541T3 (es) 2013-08-27 2024-01-22 Vasilios Voudouris Composiciones farmacéuticas de bendamustina
US10758622B2 (en) * 2015-01-21 2020-09-01 Mochida Pharmaceuticals Co., Ltd. Self-emulsifying composition of omega-3 fatty acid
PL3331568T3 (pl) * 2015-08-07 2022-02-28 Infirst Healthcare Limited Kompozycje stałego roztworu dla nlpz
CN113440481B (zh) * 2021-08-13 2022-06-14 湖南慧泽生物医药科技有限公司 伊布替尼的自微乳组合物

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US4766117A (en) * 1984-10-11 1988-08-23 Pfizer Inc. Antiinflammatory compositions and methods
US4704278A (en) * 1984-10-17 1987-11-03 American Home Products Corp (Del) Fluidized magaldrate suspension
US4676984A (en) * 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5043358A (en) * 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
US5037815A (en) * 1986-03-04 1991-08-06 Bristol-Myers Squibb Co. Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
CA2104684A1 (en) * 1991-03-04 1992-09-05 Mahdi B. Fawzi Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
IT1256345B (it) * 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
FR2710535B1 (fr) * 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
DE69412109T2 (de) * 1993-10-06 1999-01-21 Nicox S.A., Paris Salzetersaüreester mit entzündungshemmender und/oder schmerzlindernder wirkung und verfahren zu deren herstellung
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US6025395A (en) * 1994-04-15 2000-02-15 Duke University Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders
US5643960A (en) * 1994-04-15 1997-07-01 Duke University Method of delaying onset of alzheimer's disease symptoms
SI0759899T1 (en) * 1994-05-10 1999-12-31 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
SI0989851T1 (en) * 1997-07-29 2003-04-30 Pharmacia & Upjohn Company Self-emulsifying formulation for acidic lipophilic compounds
US6326028B1 (en) * 1997-10-31 2001-12-04 Monsanto Company Alginate and gellan gum as tablet coating
AU2481899A (en) * 1998-01-30 1999-08-16 Sepracor, Inc. S-lansoprazole compositions and methods
WO1999038513A1 (en) * 1998-01-30 1999-08-05 Sepracor Inc. R-lansoprazole compositions and methods
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
JP5068401B2 (ja) * 1998-09-28 2012-11-07 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ Ｈｐｍｃカプセルを使用する腸及び結腸への送達
US6485747B1 (en) * 1998-10-30 2002-11-26 Monsanto Company Coated active tablet(s)
CN1236813C (zh) * 1998-12-11 2006-01-18 药品处理公司 水难溶性药物的自乳化组合物
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6126816A (en) * 1999-07-14 2000-10-03 Ruiz, Jr.; Reuben F. Wastewater treatment device
US6787164B2 (en) * 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
SE0002476D0 (sv) * 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20020045184A1 (en) * 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
FR2818905A1 (fr) * 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile

Also Published As

Publication number Publication date
CN1416335B (zh) 2010-04-28
NO20024272D0 (no) 2002-09-06
NO20024272L (no) 2002-11-05
JP4663197B2 (ja) 2011-03-30
CZ20023005A3 (cs) 2003-02-12
HUP0300882A2 (hu) 2003-09-29
DE60103627T2 (de) 2005-06-16
CA2401498C (en) 2010-05-18
PT1267832E (pt) 2004-09-30
EE200200500A (et) 2004-02-16
SE0000773D0 (sv) 2000-03-08
IS6539A (is) 2002-09-03
BR0109014A (pt) 2003-06-03
US20030161846A1 (en) 2003-08-28
AU3787601A (en) 2001-09-17
IL151427A0 (en) 2003-04-10
KR100771317B1 (ko) 2007-10-29
DE60103627D1 (de) 2004-07-08
JP2003525894A (ja) 2003-09-02
AU2001237876B2 (en) 2005-02-17
MY127237A (en) 2006-11-30
SK285982B6 (sk) 2007-12-06
EP1267832B1 (en) 2004-06-02
DK1267832T3 (da) 2004-08-30
ZA200206740B (en) 2003-11-24
MXPA02008657A (es) 2003-02-24
CA2401498A1 (en) 2001-09-13
CN1416335A (zh) 2003-05-07
SK12572002A3 (sk) 2003-05-02
HK1050632A1 (en) 2003-07-04
EP1267832A1 (en) 2003-01-02
RU2270675C2 (ru) 2006-02-27
PL358595A1 (en) 2004-08-09
KR20030011787A (ko) 2003-02-11
HUP0300882A3 (en) 2005-04-28
ES2220728T3 (es) 2004-12-16
UA82979C2 (ru) 2008-06-10
NZ521009A (en) 2004-06-25
PL202683B1 (pl) 2009-07-31
RU2002122744A (ru) 2004-03-20
WO2001066088A1 (en) 2001-09-13
ATE268162T1 (de) 2004-06-15
CN101862453A (zh) 2010-10-20
RU2270675C9 (ru) 2006-06-27

Similar Documents

Publication Publication Date Title
TR200401906T4 (tr) Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır.
DK1267831T3 (da) Hidtil ukendt selvemulgerende system til lægemiddelindgift
DE60325183D1 (de) Verbindungseinrichtung zum medizinischen gebrauch und zum transfer von flüssigkeiten
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
TNSN01123A1 (fr) Formes posologiques nouvelles a liberation controlee
DE602004012084D1 (de) Gestreifte flüssige körperreinigungszusammensetzungen mit einer reinigungsphase und einer separaten vorteilhaften phase mit einer wasser-in-öl-emulsion
TNSN04023A1 (fr) Formulation de suspension orale stabilisee
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
BRPI0417585A (pt) composição pregabalina
SE0102993D0 (sv) New self emulsifying drug delivery system
FR2838343B1 (fr) Composition cosmetique sous forme d'emulsion multiple comprenant un agent tenseur
CO5170409A1 (es) Composiciones antitranspirantes
FR2844454B1 (fr) Composition comprenant en association au moins une huile de courge et au moins une huile de bourrache,son utilisation comme medicament, comme agent dermatologique ou dermato-cosmetique
AR028752A1 (es) Composicion adecuada para la preparacion de una emulsion de aceite en agua
CY1110841T1 (el) Σταθεροποιημενος φαρμακευτικος παραγοντας λευκοτριενιου β4 (ltb4)
BRPI0504082A (pt) emulsões refrescantes medicinais
TH100976B (th) ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่
TH100976A (th) ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่
AR027555A1 (es) Nuevo sistema de administracion de farmacos emulsionante
KR970005289A (ko) 디프사쿠스 사포닌 C(Dipsacus saponin C)를 유효성분으로 함유하는 비마약성 중추성 진통제
FR2915391B1 (fr) Composition pharmaceutique et/ou cosmetique contenant un principe actif antioxydant et activateur de l'energie cellulaire.
TH102356B (th) ระบบนำส่งยาแบบอีมัลซิฟายตัวเองชนิดใหม่
RU2004117047A (ru) Туалетная бумага
DE60123419D1 (de) Flüssige arzneizubereitungen für die orale verabreichung von unangenehm, bitterschmeckenden arzneimitteln
TH48989A3 (th) สารผสมของสารให้ความชุ่มชื้นแก่ผิวหนังซึ่งมีสารควบคุมไขผิวหนัง